IMMATICS BIOTECHNOLOGIES GMBH
Patent Owner
Stats
- 55 US PATENTS IN FORCE
- 26 US APPLICATIONS PENDING
- Mar 08, 2018 most recent publication
Details
- 55 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,886 Total Citation Count
- Mar 28, 2000 Earliest Filing
- 16 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0066,032 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERSNov 16, 17Mar 08, 18[A61K, C12Q, C12P, C12N, G01N, C07K]
2018/0037,626 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORSOct 20, 17Feb 08, 18[A61K, C12Q, C12N, G01N, C07K]
2018/0037,628 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORSOct 20, 17Feb 08, 18[A61K, C12Q, C12N, G01N, C07K]
2017/0320,913 IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLCJun 30, 17Nov 09, 17[A61K, C12N, C07K]
2017/0304,399 NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCERJun 28, 17Oct 26, 17[A61K, G01N, C07K]
2017/0296,641 PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERSMar 16, 17Oct 19, 17[A61K, C12Q, C12N, C07K]
2017/0283,431 INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHOD OF THEIR USEDec 09, 16Oct 05, 17[C07D]
2017/0189,504 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERSDec 09, 16Jul 06, 17[A61K, C12N, C07K]
2017/0189,507 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERSDec 09, 16Jul 06, 17[A61K, C12N, C07K]
2017/0158,750 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORSNov 28, 16Jun 08, 17[A61K, G01N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9908920 Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersAug 05, 16Mar 06, 18[A61K, C12Q, C12N, G01N, C07K]
9908922 Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersJun 30, 16Mar 06, 18[A61K, A01N, C12Q, C12P, C12N, G01N, C07K]
9895415 Immunotherapy against several tumors including gastrointestinal and gastric cancerJun 29, 17Feb 20, 18[A61K, G01N, C07K]
9889159 Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancersJul 14, 16Feb 13, 18[A61K, C12Q, C12P, C12N, G01N, C07K]
9862756 Peptides and combination of peptides for use in immunotherapy against various tumorsNov 28, 16Jan 09, 18[A61K, C12Q, C12N, G01N, C07K]
9840548 Peptides and combination of peptides for use in immunotherapy against various tumorsNov 28, 16Dec 12, 17[A61K, C12Q, C12N, G01N, C07K]
9802997 Peptides and combination of peptides for use in immunotherapy against various tumorsMar 28, 16Oct 31, 17[A61K, C12Q, C12N, G01N, C07K]
9791443 Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy developmentApr 15, 11Oct 17, 17[G01N, G06G]
9791444 Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy developmentApr 15, 11Oct 17, 17[G01N, G06G]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0305,992 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORSAbandonedJun 30, 17Oct 26, 17[A61K, C12Q, C12N, G01N, C07K]
2017/0037,111 Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancersAbandonedJun 30, 16Feb 09, 17[A61K, C12Q, C12P, C12N, G01N, C07K]
2016/0279,216 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORSAbandonedMar 28, 16Sep 29, 16[A61K, G01N, C07K]
2016/0279,218 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORSAbandonedMar 28, 16Sep 29, 16[A61K, G01N]
2012/0091,093 MANUFACTURE OF CLOSURES FOR FOOD CONTAINERSAbandonedMay 05, 10Apr 19, 12[B29C, B65D, B30B]
8067529 Immunogenic T-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopesExpiredSep 09, 05Nov 29, 11[C07H, C12N, C07K]
2011/0229,505 Methods for the diagnosis and treatment of cancer based on AVL9AbandonedMar 18, 11Sep 22, 11[A61K, C07H, C12Q, C12N, G01N, A61P, C07K]
2011/0070,253 TUMOUR-ASSOCIATED PEPTIDES BINDING TO MHC MOLECULESAbandonedOct 29, 10Mar 24, 11[A61K, C07H, C12N, G01N, A61P, C07K]
2009/0274,714 TUMOUR-ASSOCIATED PEPTIDES BINDING TO HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS I OR II MOLECULES AND RELATED ANTI-CANCER VACCINEAbandonedSep 05, 06Nov 05, 09[A61K, C07H, C12P, C12N, A61P, C07K]
2009/0221,509 Tumour-associated peptides binding to MHC-moleculesAbandonedMar 23, 04Sep 03, 09[A61K, C07H, C12N, G01N, C07K]
2009/0004,213 COMBINATION THERAPY USING ACTIVE IMMUNOTHERAPYAbandonedMar 25, 08Jan 01, 09[A61K, A61P]
2008/0206,216 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II MoleculesAbandonedNov 19, 07Aug 28, 08[A61K, C07H, C12P, C12N, A61P, C07K]
2006/0171,988 Method of treatment using foams as artificial lymph nodesAbandonedJan 28, 05Aug 03, 06[A61K, A61F]
2005/0221,350 Method for identifying immunoreactive peptidesAbandonedNov 29, 04Oct 06, 05[C12Q, G01N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.